\-\ Texto\\:\\ \ \(0\)\
\-\ small\\ lesions\\ \\(\\<4cm\\)\\ usually\\ not\\ treated\\.\\ \\ lesions\\ larger\\ than\\ 4cm\\ can\\ be\\ embolized\\ or\\ resected\\ due\\ to\\ increased\\ risk\\ for\\ hemorrhage\\.\ \(0\)\
\-\ ultra\\ sound\\ images\\ of\\ the\\ right\\ kidney\\ demonstrate\\ a\\ 3cm\\ hyperechoic\\ solid\\ mass\\.\ \(0\)\
\-\ axial\\ ct\\ images\\ demonstrate\\ a\\ fat\\ density\\ mass\\ in\\ the\\ right\\ kidney\\.\ \(0\)\
\-\ angiomyolipoma\ \(35\)\
\-\ for\\ hyperechoic\\ renal\\ mass\\:\ \(0\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ angiomyolipoma\ \(35\)\
\-\ hematoma\ \(500\)\
\-\ infarct\ \(514\)\
\-\ 66\\ y\\/o\\ female\\ told\\ she\\ had\\ right\\ renal\\ mass\\ by\\ physician\\ in\\ europe\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ 4cm\\:\\ 0\\.13973877361929543\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.13042928551485702\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.10815756054927834\ \(0\)\
\-\ ultra\\:\\ 0\\.10281482586590573\ \(0\)\
\-\ renal\\:\\ 0\\.0974990714984077\ \(0\)\
\-\ europe\\:\\ 0\\.08695706677102766\ \(0\)\
\-\ kidney\\:\\ 0\\.07621223936835468\ \(0\)\
\-\ sound\\:\\ 0\\.07305058210434272\ \(0\)\
\-\ told\\:\\ 0\\.07305058210434272\ \(0\)\
\-\ embolized\\:\\ 0\\.0718990406080677\ \(0\)\
\-\ 3cm\\:\\ 0\\.07034711248031665\ \(0\)\
\-\ mass\\:\\ 0\\.06017524085810453\ \(0\)\
\-\ 66\\:\\ 0\\.05817735087076445\ \(0\)\
\-\ lesions\\:\\ 0\\.05791292421123918\ \(0\)\
\-\ resected\\:\\ 0\\.05355127778855603\ \(0\)\
\-\ larger\\:\\ 0\\.052089089343975714\ \(0\)\
\-\ physician\\:\\ 0\\.05098767950866395\ \(0\)\
\-\ demonstrate\\:\\ 0\\.049783598514760524\ \(0\)\
\-\ infarct\\:\\ 0\\.04799541649519268\ \(0\)\
\-\ solid\\:\\ 0\\.04314362851273898\ \(0\)\
\-\ \\<\\:\\ 0\\.041747664905085954\ \(0\)\
\-\ images\\:\\ 0\\.041500351694920355\ \(0\)\
\-\ risk\\:\\ 0\\.03917983097922894\ \(0\)\
\-\ hematoma\\:\\ 0\\.038493251625596074\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.03600324790096247\ \(0\)\
\-\ density\\:\\ 0\\.03559027033999948\ \(0\)\
\-\ right\\:\\ 0\\.03423917882697785\ \(0\)\
\-\ fat\\:\\ 0\\.03289762434027384\ \(0\)\
\-\ usually\\:\\ 0\\.032847193086921\ \(0\)\
\-\ treated\\:\\ 0\\.03237785868460581\ \(0\)\
\-\ axial\\:\\ 0\\.03087077817807432\ \(0\)\
\-\ carcinoma\\:\\ 0\\.030657312278681854\ \(0\)\
\-\ she\\:\\ 0\\.030364381537394586\ \(0\)\
\-\ y\\/o\\:\\ 0\\.029957329491387855\ \(0\)\
\-\ cell\\:\\ 0\\.029218236855461852\ \(0\)\
\-\ due\\:\\ 0\\.028864267758896705\ \(0\)\
\-\ than\\:\\ 0\\.028342390568585746\ \(0\)\
\-\ increased\\:\\ 0\\.0264618326810083\ \(0\)\
\-\ small\\:\\ 0\\.024918674485836945\ \(0\)\
\-\ can\\:\\ 0\\.024534460157836325\ \(0\)\
\-\ had\\:\\ 0\\.02333987112962922\ \(0\)\
\-\ female\\:\\ 0\\.022237471790478906\ \(0\)\
\-\ for\\:\\ 0\\.018458434142853548\ \(0\)\
\-\ by\\:\\ 0\\.018011024091707274\ \(0\)\
\-\ be\\:\\ 0\\.0166804648524548\ \(0\)\
\-\ not\\:\\ 0\\.01563061609799918\ \(0\)\
\-\ ct\\:\\ 0\\.01513042599230434\ \(0\)\
\-\ \\:\\:\\ 0\\.01430727615178057\ \(0\)\
\-\ or\\:\\ 0\\.012677503151439335\ \(0\)\
\-\ in\\:\\ 0\\.010668284307348225\ \(0\)\
\-\ a\\:\\ 0\\.010040501311863324\ \(0\)\
\-\ \\(\\:\\ 0\\.009143819319542537\ \(0\)\
\-\ \\)\\:\\ 0\\.009032122684978544\ \(0\)\
\-\ to\\:\\ 0\\.00540592542332894\ \(0\)\
\-\ the\\:\\ 0\\.0034999818912310326\ \(0\)\
\-\ \\.\\:\\ 0\\.0022468060821105237\ \(0\)\
\-\ of\\:\\ 0\\.0014747316556707397\ \(0\)\
